Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial.

J Neurovirol · 2023 · PMC10185609 · PMID 36790601

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

nearly significantp = 0.05actually significant

Plasma BDNF A nearly significant ( p = 0.05) change in the lithium group was observed in the concentration of BDNF at the end of the intervention (Supplementary Table 1 ).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.